Lomitapide可經由抑制三酸甘油酯和膽固醇轉化為極低密度脂蛋白（VLDL），抑制乳糜微粒合成，達到降低血漿中低密度膽固醇（LDL-C）的濃度，其藥理作用機制為何？
Apo B inhibitor
mitochondrial transition pore inhibitor
proprotein convertase subtilisin/kexin type 9 inhibitor
microsomal triglyceride transfer protein inhibitor
